Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): A randomized controlled pilot study

Journal of the Medical Association of Thailand

Volumn 92, Issue 10, 2009, Pages 1273-1281

  Tasanarong, Adis ^a   Piyayotai, Dilok ^b   Thitiarchakul, Supachai ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Alpha tocopherol; Contrast induced nephropathy (CIN); Coronary procedures; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CONTRAST MEDIUM; PLACEBO; REACTIVE OXYGEN METABOLITE;

ANEMIA; ARTICLE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ALPHA-TOCOPHEROL; ANTIOXIDANTS; COMORBIDITY; CONTRAST MEDIA; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HEART DISEASES; HUMANS; KIDNEY DISEASES; MALE; PILOT PROJECTS; PREMEDICATION; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY;

EID: 70449120459     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548 (Pubitemid 30825987)
2. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461-1471 (Pubitemid 40803495)
3. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386
4. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98: 14K-20K.
5. Wong GT, Irwin MG. Contrast-induced nephropathy. Br J Anaesth 2007; 99: 474-483
6. Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98: 59K-77K. (Pubitemid 44292094)
7. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779
8. Tucker JM, Townsend DM. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother 2005; 59: 380-387 (Pubitemid 41219652)
9. Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005; 25:151-174
10. Singh U, Jialal I. Anti-inflammatory effects of alpha-tocopherol. Ann N Y Acad Sci 2004; 1031:195-203.
11. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 14-22.
12. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol 1991; 5:733-742
13. Stratta P, Canavese C, Dogliani M, Mazzucco G, Monga G, Vercellone A. The role of free radicals in the progression of renal disease. Am J Kidney Dis 1991; 17: 33-37
14. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O K. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002; 62: 1160-1170
15. Moreau JF, Noel LH, Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called "osmotic nephrosis". Invest Radiol 1993; 28: 187-190
16. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331:1416-1420 (Pubitemid 24348355)
17. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336 (Pubitemid 34127411)
18. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 553-558 (Pubitemid 37428626)
19. Tepel M, van der GM, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184 (Pubitemid 30489215)
20. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374 (Pubitemid 38406975)
21. Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2004; 2: 38.
22. Kasparek S. Chemistry of tocopherols and tocotrienols. In: Machlin LJ, editor. Vitamin E: a comprehensive treasure. New York: Marcel Dekker; 1980: 7-65.
23. Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996; 31: 671-701. (Pubitemid 26240763)
24. Radosavac D, Graf P, Polidori MC, Sies H, Stahl W. Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E. Eur J Nutr 2002; 41: 119-124
25. □zer NK, Taha S, Stocker A, Azzi A. Effects of high cholesterol, vitamin E and probucol on protein kinase C activity and proliferation of smooth muscle cells. In: Packer L, Hiramatsu M, Yoshikawa T, editors. Antioxidant food supplements and human health. London: Academic Press; 1999: 73-86.
26. Pawlak K, Mysliwiec M, Pawlak D. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine 2008; 43: 98-101.
27. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004; 66: 1988-1993
28. Stein G, Richter G, Funfstuck R, Sperschneider H, Gunther K. Serum vitamin E levels in patients with chronic renal failure. Int J Artif Organs 1983; 6: 285-287 (Pubitemid 14169362)
29. Galli F, Floridi AG, Floridi A, Buoncristiani U. Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin Nutr 2004; 23: 205-212 (Pubitemid 38401215)
30. Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, et al. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int 2003; 64: 978-991 (Pubitemid 37013834)
31. Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217-224
32. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9. (Pubitemid 29019345)
33. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267 (Pubitemid 26070354)
34. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41: 1096-1101 (Pubitemid 36548609)
35. Chaves MA, Leonart MS, do Nascimento AJ. Oxidative process in erythrocytes of individuals with hemoglobin S. Hematology 2008; 13: 187-192
36. Pavlova LE, Savov VM, Petkov HG, Charova IP. Oxidative stress in patients with beta-thalassemia major. Prilozi 2007; 28: 145-154
37. Claro LM, Leonart MS, Comar SR, do Nascimento AJ. Effect of vitamins C and E on oxidative processes in human erythrocytes. Cell Biochem Funct 2006; 24: 531-535
38. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 2006; 29: 84-93.